CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Cash flows from operating activities:
Net loss	$ (295,600,000)	$ (76,700,000)	$ (304,400,000)
Reconciliations of net loss to net cash flows provided by operating activities:
Depreciation and amortization	354,200,000	342,300,000	251,000,000
Deferred income taxes	(126,600,000)	(57,400,000)	(45,500,000)
Amortization of inventory step-up	0	11,700,000	76,500,000
Foreign exchange loss	114,000,000	43,800,000	97,300,000
Goodwill impairment	160,000,000	46,600,000	0
Gain on settlement agreement related to Series B Convertible Preferred Stock	0	(103,000,000)	0
Other, net	89,900,000	85,200,000	36,600,000
Changes in assets and liabilities, net of acquisitions:
Accounts receivable	(53,100,000)	(18,900,000)	66,700,000
Inventory	(30,300,000)	70,400,000	(7,300,000)
Accounts payable	49,800,000	(67,300,000)	83,200,000
Accrued expenses	(9,200,000)	25,400,000	51,500,000
Prepaid expenses and other current assets	(27,000,000)	(400,000)	(20,300,000)
Other assets and liabilities	(44,000,000)	(116,900,000)	35,600,000
Net cash flows provided by operating activities	182,100,000	184,800,000	320,900,000
Cash flows from investing activities:
Capital expenditures	(59,400,000)	(56,300,000)	(47,900,000)
Investment in registrations of products	(40,500,000)	(36,400,000)	(34,400,000)
Proceeds from disposal of property, plant and equipment	17,500,000	20,600,000	25,800,000
Acquisition of business, net of cash acquired	(500,000)	1,300,000	(4,600,300,000)
Restricted cash	(5,200,000)	(500,000)	599,700,000
Note receivable	0	0	(125,000,000)
Settlement of foreign exchange contracts in connection with acquisition	0	0	(73,100,000)
Other, net	(4,500,000)	(3,400,000)	(1,300,000)
Net cash flows used in investing activities	(92,600,000)	(74,700,000)	(4,256,500,000)
Cash flows from financing activities:
Debt proceeds, net of discount and premium	4,142,700,000	3,300,900,000	3,921,800,000
Repayments of borrowings	(4,122,100,000)	(3,340,100,000)	(283,700,000)
Change in lines of credit, net	(58,800,000)	54,000,000	(12,400,000)
Proceeds from issuance of common stock, net	1,400,000	391,500,000	469,500,000
Change in on-balance sheet factoring arrangements	(3,500,000)	(44,100,000)	(3,900,000)
Payment of financing fees	(13,800,000)	(1,100,000)	(87,000,000)
Settlement of Series B Convertible Preferred Stock	0	(460,000,000)	0
Other, net	(13,300,000)	(3,300,000)	(3,100,000)
Net cash flows (used in) provided by financing activities	(67,400,000)	(102,200,000)	4,001,200,000
Effect of exchange rate changes on cash and cash equivalents	33,100,000	(17,500,000)	(30,700,000)
Net increase (decrease) in cash and cash equivalents	55,200,000	(9,600,000)	34,900,000
Cash and cash equivalents at beginning of period	422,600,000	432,200,000	397,300,000
Cash and cash equivalents at end of period	477,800,000	422,600,000	432,200,000
Supplemental disclosure information:
Cash paid for interest	322,800,000	360,100,000	147,600,000
Cash paid for income taxes	$ 145,000,000	$ 121,200,000	$ 73,300,000